<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01194466</url>
  </required_header>
  <id_info>
    <org_study_id>University of Iowa 2031062</org_study_id>
    <nct_id>NCT01194466</nct_id>
  </id_info>
  <brief_title>Transcutaneous Electrical Nerve Stimulation (TENS) and Head and Neck Cancer Pain (HNC) (TENS &amp; HNC)</brief_title>
  <official_title>The Influence of TENS on Mucositis Pain and Function in Head and Neck Cancer Patients: A Randomized and Placebo-Controlled Double Blind Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Iowa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Iowa</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall goal of this study is to examine the effect of a single dose of TENS on mucositis
      pain and function secondary to head and neck radiation therapies. Oral mucositis is an
      extremely debilitating, unpreventable condition (inflammation, ulcers, bleeding in the mouth,
      nose, and throat) that causes significant pain, functional impairment, and diminished quality
      of life. Head and neck cancers pose specific challenges to effective pain management and past
      studies suggest the use of effective non-pharmacologic strategies such as TENS may be
      particularly beneficial for avoiding sources of acute and chronic pain, thereby improving
      quality of life. The investigators hypothesize that a single dose of TENS will decrease pain
      and improve function and quality of life in head and neck cancer patients. This project is
      particularly innovative because it is the first known study to examine the efficacy of TENS,
      an established safe, inexpensive and easy-to-use non-pharmacologic pain management
      intervention, for treating acute oral mucositis pain. The investigators research translates
      bench (animal model) science to human subjects using an interdisciplinary approach to pain
      management. Establishing whether TENS is effective for reducing mucositis pain is a critical
      first step toward establishing an effective, non-pharmacologic pain relief intervention for
      mucositis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 15, 2011</start_date>
  <completion_date type="Actual">August 14, 2012</completion_date>
  <primary_completion_date type="Actual">August 14, 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>10cm Visual Analog Scale (VAS)</measure>
    <time_frame>3 weeks</time_frame>
    <description>Pain intensity will be assessed at baseline (head and neck regions), immediately after each of the function tasks, and at the end of the testing session for both the head and neck locations.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Pressure Threshold</measure>
    <time_frame>3 weeks</time_frame>
    <description>A digital pressure Algometer (Somedic AB, Farsta, Sweden) will be used to measure pain threshold to deep mechanical stimuli.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cutaneous Pain Intensities (CPI's; von Frey filament)</measure>
    <time_frame>3 weeks</time_frame>
    <description>CPI's will be performed over the TMJ muscle masseter (i.e., cheek) on both sides of the face (2 CPI application sites), and two times at each site (total of 4 CPI scores). Patients will report the pain intensity of the stimulus using the 10cm VAS scale.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>Head Cancer</condition>
  <condition>Neck Cancer</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Active TENS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Active high frequency TENS will be use for Active TENS.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low Intensity TENS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low Intensity TENS will be applied for one arm of the study</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Treatment</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>TENS unit in place but not turned on</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcutaneous Electrical Nerve Stimulation (TENS)</intervention_name>
    <description>Four adhesive electrodes (1.375in x 1.375in) will be placed bilaterally on the: 1) temporomandibular joint (1/3rd of distance between ear and nose); and 2) upper neck area (2cm from spine, i.e., Cervical 1 and 2).</description>
    <arm_group_label>Active TENS</arm_group_label>
    <arm_group_label>Low Intensity TENS</arm_group_label>
    <arm_group_label>No Treatment</arm_group_label>
    <other_name>EMPI Select</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Head and Neck Cancer Diagnosis

          -  Oral mucositis diagnosis

        Exclusion Criteria:

          -  TENS use â‰¤ 5 years

          -  Pacemaker

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifer E Lee, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Iowa</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 1, 2010</study_first_submitted>
  <study_first_submitted_qc>September 1, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 3, 2010</study_first_posted>
  <last_update_submitted>March 20, 2017</last_update_submitted>
  <last_update_submitted_qc>March 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Iowa</investigator_affiliation>
    <investigator_full_name>Jennifer E. Lee</investigator_full_name>
    <investigator_title>Post Doctoral Research Fellow</investigator_title>
  </responsible_party>
  <keyword>Head and Neck Cancer</keyword>
  <keyword>Oral Cancer</keyword>
  <keyword>Laryngeal Cancer</keyword>
  <keyword>Oropharyngeal Cancer</keyword>
  <keyword>Transcutaneous Electrical Nerve Stimulation (TENS)</keyword>
  <keyword>Oral Mucositis</keyword>
  <keyword>Pain</keyword>
  <keyword>Function</keyword>
  <keyword>TENS</keyword>
  <keyword>Functional Pain</keyword>
  <keyword>Non-pharamcologic</keyword>
  <keyword>Quality of Life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

